Laboratory-Acquired Brucella abortus Infection Mimicking Autoimmune Disease: A Case Report with Genomic Confirmation
Authors:
- Judit HenczkóJHJudit Henczkó
- Zsuzsa KienleZKZsuzsa Kienle
- János KádárJKJános Kádár
- Enikő Kádár-HürkeczEKEnikő Kádár-Hürkecz
- Katalin Tárnoki-BorossKTKatalin Tárnoki-Boross
- Panna SütőPSPanna Sütő
- Bernadett PályiBPBernadett Pályi
- Ákos TóthÁTÁkos Tóth
- Katalin KamotsayKKKatalin Kamotsay
- Zsuzsanna MolnárZMZsuzsanna Molnár
- Zoltan KisZKZoltan Kis
Open Access
Abstract
Background: Brucellosis is a globally distributed zoonotic disease characterized by highly variable clinical manifestations that may mimic systemic autoimmune and inflammatory disorders. In Europe, where the incidence of brucellosis is relatively low, limited clinical awareness may contribute to delayed diagnosis and inappropriate management. In addition to zoonotic transmission, Brucella species are a well-recognized cause of laboratory-acquired infections (LAIs) among microbiology laboratory personnel. Methods: We report a case of laboratory-acquired Brucella abortus infection in a young woman presenting with undulant fever, arthralgia, systemic inflammation, elevated ferritin levels, and antinuclear antibody (ANA) positivity. Microbiological confirmation was achieved through serological testing (ELISA), repeat blood cultures, species-specific quantitative PCR, and whole-genome sequencing (WGS) followed by core genome multilocus sequence typing (cgMLST). Results: Initial laboratory evaluation revealed elevated C-reactive protein, mildly increased ferritin levels (146 ng/mL), abnormal liver enzyme levels, and rising ANA titers (from 1:160 to 1:320), raising suspicion of a systemic autoimmune disorder and prompting consideration of corticosteroid therapy. Although the initial blood culture was negative, subsequent molecular diagnostics and repeat cultures confirmed B. abortus infection. Epidemiological investigation suggested a possible occupational exposure in a diagnostic microbiology laboratory, consistent with a laboratory-acquired infection. Genomic analysis classified the isolate as sequence type 1 (ST1) and demonstrated zero allelic differences compared with the ST1 reference strain. Targeted antimicrobial therapy resulted in complete clinical recovery, supporting an infection-triggered immune response rather than primary autoimmunity. Conclusions: Acute brucellosis should be considered in the differential diagnosis of febrile syndromes accompanied by autoimmune-like laboratory abnormalities, even in low-incidence regions. This case highlights the diagnostic challenges posed by laboratory-acquired brucellosis and underscores the importance of early microbiological investigation and strict biosafety awareness in laboratory settings.Keywords
This publication has 23 references indexed in Scilit:
- Laboratory-acquired infection in clinical laboratories and the incidence rate after Brucella exposure risk events: a systematic review and meta-analysisJournal of Hospital Infection, 2024
- Laboratory-acquired infections and pathogen escapes worldwide between 2000 and 2021: a scoping reviewThe Lancet Microbe, 2023
- Core Genome Multilocus Sequence Typing Scheme for Improved Characterization and Epidemiological Surveillance of Pathogenic BrucellaJournal of Clinical Microbiology, 2022
- The Lanzhou Brucella Leak: The Largest Laboratory Accident in the History of Infectious Diseases?Clinical Infectious Diseases, 2022
- Clinical Characteristics of a Zoonotic Occupational Disease—Brucella endocarditis with Review of LiteratureIndian Journal of Cardiovascular Disease in Women, 2022
- Prevalence of positive autoimmune biomarkers in the brucellosis patientsClinical Rheumatology, 2016
- A Literature Review of Laboratory-Acquired BrucellosisJournal of Clinical Microbiology, 2013
- Brucellosis of the European Brown Hare (Lepus europaeus)Journal of Comparative Pathology, 2011
- Human brucellosisThe Lancet Infectious Diseases, 2007
- An Overview of Human BrucellosisClinical Infectious Diseases, 1995